Adelaide Research & Scholarship
Browsing "Medicine publications" by Author Ross, L.
Showing results 1 to 6 of 6
| Preview | Issue Date | Title | Author(s) |
| 2020 | Can patient-reported symptoms be used to measure disease activity in systemic sclerosis? | Ross, L.; Stevens, W.; Wilson, M.; Strickland, G.; Walker, J.; Sahhar, J.; Ngian, G.-S.; Roddy, J.; Major, G.; Proudman, S.; Baron, M.; Nikpour, M. |
| 2023 | Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis. | Fairley, J.L.; Hansen, D.; Ross, L.; Proudman, S.; Sahhar, J.; Ngian, G.-S.; Walker, J.; Host, L.V.; Morrisroe, K.; Apostolopoulous, D.; Ferdowsi, N.; Wilson, M.; Tabesh, M.; Stevens, W.; Nikpour, M.; Australian Scleroderma Interest Group, |
| 2019 | Defining primary systemic sclerosis heart involvement: a scoping literature review | Ross, L.; Prior, D.; Proudman, S.; Vacca, A.; Baron, M.; Nikpour, M. |
| 2022 | Evaluation of patient and physician assessments of gastrointestinal disease activity in systemic sclerosis | Ross, L.; Proudman, S.; Walker, J.; Stevens, W.; Ferdowsi, N.; Quinlivan, A.; Morrisroe, K.; Baron, M.; Nikpour, M. |
| 2020 | Performance of the 2017 EUSTAR activity index in an scleroderma cohort | Ross, L.; Stevens, W.; Wilson, M.; Huq, M.; Strickland, G.; Walker, J.; Sahhar, J.; Ngian, G.S.; Roddy, J.; Youssef, P.; Proudman, S.; Nikpour, M. |
| 2019 | Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis | Moxey, J.; Huq, M.; Proudman, S.; Sahhar, J.; Ngian, G.S.; Walker, J.; Strickland, G.; Wilson, M.; Ross, L.; Major, G.; Roddy, J.; Stevens, W.; Nikpour, M. |
